Lion Files First Patent Application for Lead Compounds | GenomeWeb

NEW YORK, Aug. 16 – Bioinformatics company Lion Bioscience of Heidelberg, Germany, said Thursday it had filed for patent protection for a series of lead compounds it had developed.  

The announcement marks Lion’s first such application and comes just 16 months after the company launched its drug discovery efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.